NCEL NewcelX Ltd.
$3.30▼ -0.91%
Healthcare
Other
After hours
$3.30▼ -0.14%
Sep 11, 7:30 PM ET
Volume 3.7K
Avg Volume (10D) 7.5K
Key Metrics & Fundamentals
Market Cap
$19.09M
P/E Ratio
–
Div Yield
–%
52W Range
1.83 - 24.60
% vs 50 MA
-7.03%
% vs 200 MA
6.35%
RSI-14
47.0
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.18
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
GlobeNewswire · Jul 31, 2026 1:00 PM
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
GlobeNewswire · Jul 15, 2026 1:00 PM
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
GlobeNewswire · Jul 8, 2026 1:15 PM
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
GlobeNewswire · Jul 1, 2026 1:30 PM
NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
GlobeNewswire · Jun 15, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for NCEL.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.